BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND B2M, P61769, 567, ENSG00000166710 AND Treatment
45 results:

  • 1. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Efficacy, prognosis and influencing factors of transcatheter arterial embolization in the treatment of neuroendocrine neoplasm liver metastases].
    Zhang Y; Xu RT; Bai JA; Hu P; Li XY; Tian Y; Tang QY
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2952-2958. PubMed ID: 37752055
    [No Abstract]    [Full Text] [Related]  

  • 3. Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
    Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
    JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
    Koyama J; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
    Int J Urol; 2023 Nov; 30(11):1044-1050. PubMed ID: 37522577
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epigenetic control of
    Wang MM; Koskela SA; Mehmood A; Langguth M; Maranou E; Figueiredo CR
    Front Immunol; 2023; 14():1152228. PubMed ID: 37077920
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
    Žilionytė K; Bagdzevičiūtė U; Mlynska A; Urbštaitė E; Paberalė E; Dobrovolskienė N; Krasko JA; Pašukonienė V
    Cancer Immunol Immunother; 2022 Nov; 71(11):2691-2700. PubMed ID: 35364740
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
    Aglietta M; Chiarion-Sileni V; Fava P; Guidoboni M; Depenni R; Minisini A; Consoli F; Ascierto P; Rinaldi G; Banzi M; Marconcini R; Gueli R; Ferraresi V; Tucci M; Tonini G; Lo Re G; Guida M; Del Vecchio M; Marcon IG; Queirolo P
    Target Oncol; 2021 Nov; 16(6):789-799. PubMed ID: 34755244
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
    Patel AB; Farooq S; Welborn M; Amaria RN; Chon SY; Diab A; Glitza Oliva IC; Huen AO; Li SQ; Nelson KC; Pacha O; Patel SP; Rapini RP; Tawbi HA; Wong MK; McQuade J; Davies MA; Haydu LE
    Cancer; 2022 Mar; 128(5):975-983. PubMed ID: 34724197
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study.
    Son J; Park IJ; Yang DH; Kim J; Kim KJ; Byeon JS; Hong SM; Kim YI; Kim JB; Lim SB; Yu CS; Kim JC
    Surg Endosc; 2022 Apr; 36(4):2445-2455. PubMed ID: 34009477
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States.
    Boczar D; Bagaria SP; Spaulding AC; Huayllani MT; Avila FR; Guliyeva G; Lu X; Rinker BD; Forte AJ
    Anticancer Res; 2021 Apr; 41(4):2067-2070. PubMed ID: 33813415
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. b2m overexpression correlates with malignancy and immune signatures in human gliomas.
    Zhang H; Cui B; Zhou Y; Wang X; Wu W; Wang Z; Dai Z; Cheng Q; Yang K
    Sci Rep; 2021 Mar; 11(1):5045. PubMed ID: 33658560
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry.
    Martinez-Morilla S; Villarroel-Espindola F; Wong PF; Toki MI; Aung TN; Pelekanou V; Bourke-Martin B; Schalper KA; Kluger HM; Rimm DL
    Clin Cancer Res; 2021 Apr; 27(7):1987-1996. PubMed ID: 33504554
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Peptide receptor radiotherapy re-treatment in patients with progressive neuroendocrine tumors: A systematic review and meta-analysis.
    Strosberg J; Leeuwenkamp O; Siddiqui MK
    Cancer Treat Rev; 2021 Feb; 93():102141. PubMed ID: 33418096
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive analysis of cutaneous and uveal melanoma liver metastases.
    Hoefsmit EP; Rozeman EA; Van TM; Dimitriadis P; Krijgsman O; Conway JW; Pires da Silva I; van der Wal JE; Ketelaars SLC; Bresser K; Broeks A; Kerkhoven RM; Reeves JW; Warren S; Kvistborg P; Scolyer RA; Kapiteijn EW; Peeper DS; Long GV; Schumacher TNM; Blank CU
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33262254
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognosticating role of serum eosinophils on immunotherapy efficacy in patients with advanced melanoma.
    Kartolo A; Holstead R; Hopman W; Baetz T
    Immunotherapy; 2021 Feb; 13(3):217-225. PubMed ID: 33238773
    [No Abstract]    [Full Text] [Related]  

  • 16. Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma.
    Thompson JC; Davis C; Deshpande C; Hwang WT; Jeffries S; Huang A; Mitchell TC; Langer CJ; Albelda SM
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028693
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Inhibition of MICA and MICB Shedding Elicits NK-cell-Mediated Immunity against tumors Resistant to Cytotoxic T cells.
    Ferrari de Andrade L; Kumar S; Luoma AM; Ito Y; Alves da Silva PH; Pan D; Pyrdol JW; Yoon CH; Wucherpfennig KW
    Cancer Immunol Res; 2020 Jun; 8(6):769-780. PubMed ID: 32209637
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
    Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
    JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Role of Radiotherapy for Chordoma Patients Managed With Surgery: Analysis of the National Cancer Database.
    Dial BL; Kerr DL; Lazarides AL; Catanzano AA; Green CL; Risoli T; Blazer DG; Goodwin RC; Brigman BE; Eward WC; Larrier NA; Kirsch DG; Mendoza-Lattes SA
    Spine (Phila Pa 1976); 2020 Jun; 45(12):E742-E751. PubMed ID: 32032324
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma.
    Choi BD; Yu X; Castano AP; Darr H; Henderson DB; Bouffard AA; Larson RC; Scarfò I; Bailey SR; Gerhard GM; Frigault MJ; Leick MB; Schmidts A; Sagert JG; Curry WT; Carter BS; Maus MV
    J Immunother Cancer; 2019 Nov; 7(1):304. PubMed ID: 31727131
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.